In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents
Olorofim is a novel antifungal drug that belongs to the orotomide drug class which inhibits fungal dihydroorotate dehydrogenase (DHODH), thus halting pyrimidine biosynthesis and ultimately DNA synthesis, cell growth and division. It is being developed at a time when many invasive fungal infections e...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/7/5/378 |
id |
doaj-356ca938388c4e69a7c33add6501103f |
---|---|
record_format |
Article |
spelling |
doaj-356ca938388c4e69a7c33add6501103f2021-05-31T23:45:27ZengMDPI AGJournal of Fungi2309-608X2021-05-01737837810.3390/jof7050378In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal AgentsOurania Georgacopoulos0Natalie S. Nunnally1Eric M. Ransom2Derek Law3Mike Birch4Shawn R. Lockhart5Elizabeth L. Berkow6Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USAMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USAAssociation of Public Health Laboratories, Silver Springs, MD 20910, USAF2G Ltd., Manchester M30 0LX, UKF2G Ltd., Manchester M30 0LX, UKMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USAMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USAOlorofim is a novel antifungal drug that belongs to the orotomide drug class which inhibits fungal dihydroorotate dehydrogenase (DHODH), thus halting pyrimidine biosynthesis and ultimately DNA synthesis, cell growth and division. It is being developed at a time when many invasive fungal infections exhibit antifungal resistance or have limited treatment options. The goal of this study was to evaluate the in vitro effectiveness of olorofim against a large collection of recently isolated, clinically relevant American mold isolates. In vitro antifungal activity was determined for 246 azole-susceptible <i>Aspergillus fumigatus</i> isolates, five <i>A. fumigatus</i> with TR<sub>34</sub>/L98H-mediated resistance, 19 <i>Rhizopus</i> species isolates, 21 <i>Fusarium</i> species isolates, and one isolate each of six other species of molds. Olorofim minimum inhibitory concentrations (MICs) were compared to antifungal susceptibility testing profiles for amphotericin B, anidulafungin, caspofungin, isavuconazole, itraconazole, micafungin, posaconazole, and voriconazole. Olorofim MICs were significantly lower than those of the echinocandin and azole drug classes and amphotericin B. <i>A. fumigatus</i> wild type and resistant isolates shared the same MIC50 = 0.008 μg/mL. In non-<i>Aspergillus</i> susceptible isolates (MIC ≤ 2 μg/mL), the geometric mean (GM) MIC to olorofim was 0.54 μg/mL with a range of 0.015–2 μg/mL. Olorofim had no antifungal activity (MIC ≥ 2 μg/mL) against 10% of the collection (31 in 297), including some isolates from <i>Rhizopus</i> spp. and <i>Fusarium</i> spp. Olorofim showed promising activity against <i>A. fumigatus</i> and other molds regardless of acquired azole resistance.https://www.mdpi.com/2309-608X/7/5/378olorofimF901318filamentous fungiantifungal agents<i>Aspergillus fumigatus</i><i>Fusarium</i> spp. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ourania Georgacopoulos Natalie S. Nunnally Eric M. Ransom Derek Law Mike Birch Shawn R. Lockhart Elizabeth L. Berkow |
spellingShingle |
Ourania Georgacopoulos Natalie S. Nunnally Eric M. Ransom Derek Law Mike Birch Shawn R. Lockhart Elizabeth L. Berkow In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents Journal of Fungi olorofim F901318 filamentous fungi antifungal agents <i>Aspergillus fumigatus</i> <i>Fusarium</i> spp. |
author_facet |
Ourania Georgacopoulos Natalie S. Nunnally Eric M. Ransom Derek Law Mike Birch Shawn R. Lockhart Elizabeth L. Berkow |
author_sort |
Ourania Georgacopoulos |
title |
In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents |
title_short |
In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents |
title_full |
In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents |
title_fullStr |
In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents |
title_full_unstemmed |
In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents |
title_sort |
in vitro activity of novel antifungal olorofim against filamentous fungi and comparison to eight other antifungal agents |
publisher |
MDPI AG |
series |
Journal of Fungi |
issn |
2309-608X |
publishDate |
2021-05-01 |
description |
Olorofim is a novel antifungal drug that belongs to the orotomide drug class which inhibits fungal dihydroorotate dehydrogenase (DHODH), thus halting pyrimidine biosynthesis and ultimately DNA synthesis, cell growth and division. It is being developed at a time when many invasive fungal infections exhibit antifungal resistance or have limited treatment options. The goal of this study was to evaluate the in vitro effectiveness of olorofim against a large collection of recently isolated, clinically relevant American mold isolates. In vitro antifungal activity was determined for 246 azole-susceptible <i>Aspergillus fumigatus</i> isolates, five <i>A. fumigatus</i> with TR<sub>34</sub>/L98H-mediated resistance, 19 <i>Rhizopus</i> species isolates, 21 <i>Fusarium</i> species isolates, and one isolate each of six other species of molds. Olorofim minimum inhibitory concentrations (MICs) were compared to antifungal susceptibility testing profiles for amphotericin B, anidulafungin, caspofungin, isavuconazole, itraconazole, micafungin, posaconazole, and voriconazole. Olorofim MICs were significantly lower than those of the echinocandin and azole drug classes and amphotericin B. <i>A. fumigatus</i> wild type and resistant isolates shared the same MIC50 = 0.008 μg/mL. In non-<i>Aspergillus</i> susceptible isolates (MIC ≤ 2 μg/mL), the geometric mean (GM) MIC to olorofim was 0.54 μg/mL with a range of 0.015–2 μg/mL. Olorofim had no antifungal activity (MIC ≥ 2 μg/mL) against 10% of the collection (31 in 297), including some isolates from <i>Rhizopus</i> spp. and <i>Fusarium</i> spp. Olorofim showed promising activity against <i>A. fumigatus</i> and other molds regardless of acquired azole resistance. |
topic |
olorofim F901318 filamentous fungi antifungal agents <i>Aspergillus fumigatus</i> <i>Fusarium</i> spp. |
url |
https://www.mdpi.com/2309-608X/7/5/378 |
work_keys_str_mv |
AT ouraniageorgacopoulos invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents AT nataliesnunnally invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents AT ericmransom invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents AT dereklaw invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents AT mikebirch invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents AT shawnrlockhart invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents AT elizabethlberkow invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents |
_version_ |
1721416702646812672 |